Announcements Trials
Browse Landscape

Phase

Phase 2 284Phase 1 143Phase 3 74Phase 1/2 71Phase NA 25Phase 4 12Phase 2/3 11Phase EARLY_PHASE1 3

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 61Cyclophosphamide 57pembrolizumab 39fludarabine 38Radiotherapy 30Nivolumab 30Biopsy 27Metformin 23Fluorodeoxyglucose F18 22Bevacizumab 22Specimen Handling 21Temozolomide 18Cisplatin 18Radiosurgery 17Carboplatin 16Fluorouracil 15Paclitaxel 14Dexamethasone 14Radiation 13Gemcitabine 13Etoposide 13Rituximab 12Positron Emission Tomography Computed Tomography 12Letrozole 12Irinotecan 12gallium 68 PSMA-11 11durvalumab 11atezolizumab 11X-Rays 11Surgical Procedures, Operative 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Sorafenib × Clear all
NCT06797427 2025-03-17

A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers

Disruptive Pharma

Phase EARLY_PHASE1 Completed
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00405366 2017-04-18

NRR

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
30 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01337492 2012-03-21

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
2 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡